Ads
related to: examples of ethylhexanoate drugs at home page for patients with diabetes- Medication Guidelines
Learn about medication guidelines
For US Healthcare Professionals.
- Dosing Data
Dosing Considerations And Data For
US Healthcare Professionals.
- Medication Guidelines
Search results
Results From The WOW.Com Content Network
There are different classes of hypoglycemic drugs, and selection of the appropriate agent depends on the nature of diabetes, age, and situation of the person, as well as other patient factors. Type 1 diabetes is a disease caused by the lack of insulin. Thus, insulin is the main treatment agent for type 1 and is typically administered via ...
Pramlintide has been approved on 3/16/2005 by the FDA, for use by type 1 and type 2 diabetic patients who use insulin. [6] (subscription required) Pramlintide allows patients to use less insulin, lowers average blood sugar levels, and substantially reduces what otherwise would be a large unhealthy rise in blood sugar that occurs in diabetics right after eating.
This page was last edited on 31 December 2022, at 00:01 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Chromium(III) 2-ethylhexanoate; H. Hydroxyl aluminium bis(2-ethylhexanoate) P. Potassium 2-ethylhexanoate; T. ... This page was last edited on 29 October 2023, ...
Exenatide, sold under the brand name Byetta among others, is a medication used to treat type 2 diabetes. [7] It is used together with diet, exercise, and potentially other antidiabetic medication. [7]
A 2020 Cochrane systematic review did not find enough evidence of reduction of all-cause mortality, serious adverse events, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to meglitinide for the treatment of type 2 diabetes.
Ads
related to: examples of ethylhexanoate drugs at home page for patients with diabetes